Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia

BACKGROUND & AIMS: Thrombocytopaenia and hypoalbuminaemia are surrogate markers for portal hypertension and hepatic synthetic dysfunction respectively. Patients infected with hepatitis C virus (HCV) with these surrogates have reduced likelihood of sustained virologic response and increased risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Forns, Xavier, Poordad, Fred, Pedrosa, Marcos, Berenguer, Marina, Wedemeyer, Heiner, Ferenci, Peter, Shiffman, Mitchell L., Fried, Michael W., Lovell, Sandra, Trinh, Roger, Lopez‐Talavera, Juan Carlos, Everson, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049489/
https://www.ncbi.nlm.nih.gov/pubmed/26248955
http://dx.doi.org/10.1111/liv.12931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049489/
https://www.ncbi.nlm.nih.gov/pubmed/26248955
http://dx.doi.org/10.1111/liv.12931

Ejemplares similares